Literature DB >> 27039217

Incidentalomas associated with abdominal and pelvic CT angiograms for abdominal-based breast free flap reconstruction.

Olivia A Ho1, Shaghayegh Bagher2, Jeff Jaskolka2, Marcus Tan2, Kate Butler2, Anne C O'Neill2, Toni Zhong2, Stefan O Hofer2.   

Abstract

Computed tomography angiography (CTA) is routinely performed prior to breast reconstruction using deep inferior epigastric perforator (DIEP) flaps to provide better surgical planning and improve preoperative decision making. These investigations occasionally result in unexpected findings in otherwise asymptomatic women. Unexpected findings on imaging in a population of women with previous breast cancer or strong breast cancer risk factors can lead to undue stress and anxiety. The aim of this study is to determine the incidence of unexpected findings in preoperative CT angiograms and to correlate these with patient and breast cancer characteristics. A retrospective chart review from May 2008 to December 2012 was performed reviewing all patients who underwent DIEP flap breast reconstruction. Radiology reports of their preoperative CT angiograms, details of unexpected findings, patients' past medical and cancer history, additional radiological investigations, outcomes, and interventions were reviewed. In total, 360 patients met the inclusion criteria for the study. Sixty-four percent of the patients who underwent CTA imaging had incidental findings. Further imaging was suggested in 48% of this group. The most common incidentalomas were hepatic (47%), bone (24%), and renal (20%). "Incidentalomas" were associated with patients' underlying comorbidities (p = 0.001) and age (p = 0.01). "Radiographically suspicious incidentalomas" were associated with the underlying comorbidities (p = 0.001). The radiologists most commonly suggested investigation methods such as ultrasound (41%), another CT (28%), bone scan (21%), and magnetic resonance imaging (MRI; 14%). No incidentalomas were found to be malignant on further recommended investigation in this study and no breast cancer reconstruction was delayed as a result of the discovery of incidentalomas or their subsequent investigations. It is important to counsel patients of the possibility of incidental findings and the resulting sequelae prior to CTA investigations for breast cancer reconstruction and involve them in shared decision making if additional investigations are required.
Copyright © 2016 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast reconstruction; CTA; Cost; Deep inferior epigastric perforator; Incidentalomas; Radiographic studies

Mesh:

Year:  2016        PMID: 27039217     DOI: 10.1016/j.bjps.2016.01.023

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

1.  Improving Incidental Finding Documentation in Trauma Patients Amidst Poor Access to Follow-up Care.

Authors:  Marguerite W Spruce; Jessica A Bowman; Alice J Wilson; Joseph M Galante
Journal:  J Surg Res       Date:  2019-12-26       Impact factor: 2.192

2.  Concordance between preoperative computed tomography angiographic mapping and intraoperative perforator selection for deep inferior epigastric artery perforator flap breast reconstructions.

Authors:  Vivian B Boer; Jan J van Wingerden; Carolien F Wever; Joost J Kardux; Michiel R Beets; Hester J van der Zaag-Loonen; Willem J Theuvenet
Journal:  Gland Surg       Date:  2017-12

3.  Preoperative Computed Tomography Angiography in Autologous Breast Reconstruction-Incidence and Impact of Incidentalomas.

Authors:  Ruth Tevlin; Mimi R Borrelli; Dung Nguyen; Arash Momeni
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-12-12

4.  Incidental Findings in CT and MR Angiography for Preoperative Planning in DIEP Flap Breast Reconstruction.

Authors:  Ryan D Wagner; Andres F Doval; Nikhilesh V Mehra; Hung B Le; Paul A Niziol; Warren A Ellsworth; Aldona J Spiegel
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.